Press Release

Accuro Biologics Ltd to present at IBC "Antibodies and Beyond Antibodies" conference June 1-2 2006

ABERDEEN, UK -- May 10, 2006 --- Accuro Biologics Ltd, a privately held biotechnology services company, announces that Managing Director Graham Carter is to present at an international scientific conference. The conference entitled "Antibodies and Beyond Antibodies, Optimizing Leads and Exploring Next Generation Scaffolds for Protein Therapeutics" is organised by IBC Inc and will take place at the Loew's Coronado Bay Resort Hotel, Coronado, CA, USA on June 1 - 2, 2006.

The conference is considered a premier event addressing antibody alternatives as well as the emerging frontier of next generation antibodies in drug development. The event will bring together an international audience of leading companies from the USA, Australia, Europe and Asia Pacific to discuss scientific advances and business opportunities in this field, and to compare the opportunities and challenges of novel antibody-based techniques and next generation scaffolds for protein therapeutics.

In his presentation, Graham Carter will discuss strategies for immunogenicity risk assessment and risk limitation and show how the capabilities of Accuro Biologics contribute to this important area of biotechnological development.

About Accuro Biologics Ltd

Accuro Biologics is a research services company serving the pharmaceutical, biotechnology and wider research community to provide access to advanced capabilities in protein and antibody engineering, mammalian cell line engineering and immunogenicity profiling. The company is UK-based and operates from its own fully equipped laboratories within the Aberdeen Science and Technology Park (Aberdeen, Scotland). For more information, please contact:

Graham Carter
Managing Director
Tel: +44 (0)1224 707337
Email: graham.carter@accurobio.com

Return to Press Releases